THE 2-MINUTE RULE FOR AZELAPRAG CLINICAL TRIALS

AMG 986 exposures greater nonlinearly with escalating doses; negligible accumulation was noticed. In HF with lowered ejection fraction clients, there have been numerical increases in % variations from baseline in LV ejection fraction and stroke volume by volumetric assessment with AMG 986 vs placebo (stroke volume enhance not recapitulated by Doppl